{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:19:02Z","timestamp":1790403542943,"version":"4.1.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients hospitalized for pneumonia are at high risk for mortality. Effective therapies are therefore needed. Recent randomized clinical trials suggest that systemic steroids can reduce the length of hospital stays among patients hospitalized for pneumonia. Furthermore, preliminary findings from a feasibility study demonstrated that early treatment with a combination of an inhaled corticosteroid and a bronchodilator can improve oxygenation and reduce risk of respiratory failure in patients at risk of acute respiratory distress syndrome. Whether such a combination administered early is effective in reducing acute respiratory failure (ARF) among patients hospitalized with pneumonia is unknown. Here we describe the ARREST Pneumonia (Arrest Respiratory Failure due to Pneumonia) trial designed to address this question. ARREST Pneumonia is a two-arm, randomized, double-blinded, placebo-controlled trial designed to test the efficacy of a combination of an inhaled corticosteroid and a \u03b2-agonist compared with placebo for the prevention of ARF in hospitalized participants with severe pneumonia. The primary outcome is ARF within 7 days of randomization, defined as a composite endpoint of intubation and mechanical ventilation; need for high-flow nasal cannula oxygen therapy or noninvasive ventilation for &amp;gt;36 hours (each alone or combined); or death within 36 hours of being placed on respiratory support. The planned enrollment is 600 adult participants at 10 academic medical centers. In addition, we will measure selected plasma biomarkers to better understand mechanisms of action. The trial is funded by the U.S. National Heart Lung and Blood Institute.<\/jats:p>\n                  <jats:p>Clinical trial registered with www.clinicaltrials.gov (NCT 04193878).<\/jats:p>","DOI":"10.1513\/annalsats.202009-1115sd","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T17:45:51Z","timestamp":1611596751000},"page":"698-708","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":8,"title":["The ARREST Pneumonia Clinical Trial. Rationale and Design"],"prefix":"10.1093","volume":"18","author":[{"given":"Joseph E.","family":"Levitt","sequence":"first","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2002-4248","authenticated-orcid":false,"given":"Emir","family":"Festic","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine and"},{"name":"Department of Critical Care, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Desai","sequence":"additional","affiliation":[{"name":"Stanford Center for Biomedical Informatics and Research, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Hedlin","sequence":"additional","affiliation":[{"name":"Stanford Center for Biomedical Informatics and Research, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Mahaffey","sequence":"additional","affiliation":[{"name":"Stanford Center for Clinical Research, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela J.","family":"Rogers","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy and Critical Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ognjen","family":"Gajic","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine and"},{"name":"Department of Critical Care, Mayo Clinic, Rochester, Minnesota; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Matthay","sequence":"additional","affiliation":[{"name":"Pulmonary, Critical Care, Allergy and Sleep Medicine Program, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,1]]},"reference":[{"key":"2026012203473819600_bib1","article-title":"Costs for hospital stays in the United States, 2011: statistical brief #168","volume-title":"Healthcare Cost and Utilization Project (HCUP) statistical briefs","author":"Pfuntner","year":"2006"},{"key":"2026012203473819600_bib2","article-title":"Most frequent conditions in US hospitals, 2011: statistical brief #162","volume-title":"Healthcare Cost and Utilization Project (HCUP) statistical briefs","author":"Pfuntner","year":"2006"},{"key":"2026012203473819600_bib3","first-page":"1","article-title":"Deaths: leading causes for 2011. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics","volume":"64","author":"Heron","year":"2015","journal-title":"National Vital Statistics System"},{"key":"2026012203473819600_bib4","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/ajrccm.158.4.9803114","article-title":"Severe community-acquired pneumonia: assessment of severity criteria","volume":"158","author":"Ewig","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203473819600_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1378\/chest.07-0306","article-title":"Pneumonia severity index class V patients with community-acquired pneumonia: characteristics, outcomes, and value of severity scores","volume":"132","author":"Valencia","year":"2007","journal-title":"Chest"},{"key":"2026012203473819600_bib6","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJM200005043421806","article-title":"The acute respiratory distress syndrome","volume":"342","author":"Ware","year":"2000","journal-title":"N Engl J Med"},{"key":"2026012203473819600_bib7","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"key":"2026012203473819600_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"2026012203473819600_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/M15-0715","article-title":"Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis","volume":"163","author":"Siemieniuk","year":"2015","journal-title":"Ann Intern Med"},{"key":"2026012203473819600_bib10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial","volume":"181","author":"Snijders","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203473819600_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1164\/ajrccm.150.2.8049807","article-title":"Alveolar fluid clearance in the resected human lung","volume":"150","author":"Sakuma","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203473819600_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1164\/rccm.200508-1302OC","article-title":"The Beta-Agonist Lung Injury Trial (BALTI): a randomized placebo-controlled clinical trial","volume":"173","author":"Perkins","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203473819600_bib13","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/CCM.0000000000002284","article-title":"Randomized clinical trial of a combination of an inhaled corticosteroid and beta agonist in patients at risk of developing the acute respiratory distress syndrome","volume":"45","author":"Festic","year":"2017","journal-title":"Crit Care Med"},{"key":"2026012203473819600_bib14","article-title":"Dexamethasone in hospitalized patients with COVID-19: preliminary report","author":"Horby","journal-title":"N Engl J Med"},{"key":"2026012203473819600_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/biomet\/58.3.403","article-title":"Forcing a sequential experiment to be balanced","volume":"58","author":"Efron","year":"1971","journal-title":"Biometrika"},{"key":"2026012203473819600_bib16","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure","volume":"372","author":"Frat","year":"2015","journal-title":"N Engl J Med"},{"key":"2026012203473819600_bib17","first-page":"CD010172","article-title":"High-flow nasal cannulae for respiratory support in adult intensive care patients","volume":"5","author":"Corley","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012203473819600_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2026012203473819600_bib19","doi-asserted-by":"crossref","first-page":"346ra91","DOI":"10.1126\/scitranslmed.aaf7165","article-title":"Robust classification of bacterial and viral infections via integrated host gene expression diagnostics","volume":"8","author":"Sweeney","year":"2016","journal-title":"Sci Transl Med"},{"key":"2026012203473819600_bib20","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1177\/0962280214545121","article-title":"A \u201cplacement of death\u201d approach for studies of treatment effects on ICU length of stay","volume":"26","author":"Lin","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"2026012203473819600_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U","article-title":"The nonparametric Behrens-Fisher problem: asymptotic theory and a small-sample approximation","volume":"42","author":"Brunner","year":"2000","journal-title":"Biometrical J."},{"key":"2026012203473819600_bib22","article-title":"ldbounds: Lan-DeMets method for group sequential boundaries","author":"Casper"},{"key":"2026012203473819600_bib23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0197-2456(00)00057-X","article-title":"Computations for group sequential boundaries using the Lan-DeMets spending function method","volume":"21","author":"Reboussin","year":"2000","journal-title":"Control Clin Trials"},{"key":"2026012203473819600_bib24","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/thx.2008.105312","article-title":"Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia","volume":"64","author":"Men\u00e9ndez","year":"2009","journal-title":"Thorax"},{"key":"2026012203473819600_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcrc.2010.07.014","article-title":"Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study","volume":"26","author":"Salluh","year":"2011","journal-title":"J Crit Care"},{"key":"2026012203473819600_bib26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1165\/rcmb.2015-0071OC","article-title":"Glucocorticoids regulate tight junction permeability of lung epithelia by modulating claudin 8","volume":"54","author":"Kielgast","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026012203473819600_bib27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/bcp.12857","article-title":"Dissociation between systemic and pulmonary anti-inflammatory effects of dexamethasone in humans","volume":"81","author":"Bartko","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"2026012203473819600_bib28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mayocp.2013.10.028","article-title":"Prehospital use of inhaled corticosteroids and point prevalence of pneumonia at the time of hospital admission: secondary analysis of a multicenter cohort study","volume":"89","author":"Festic","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"2026012203473819600_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5644\/ama2006-124.138","article-title":"Pre-hospital use of inhaled corticosteroids and inhaled beta agonists and incidence of ARDS: a population-based study","volume":"44","author":"Mangi","year":"2015","journal-title":"Acta Med Acad"},{"key":"2026012203473819600_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/anae.12479","article-title":"Therapeutic effect of inhaled budesonide (Pulmicort\u00ae Turbuhaler) on the inflammatory response to one-lung ventilation","volume":"69","author":"Ju","year":"2014","journal-title":"Anaesthesia"},{"key":"2026012203473819600_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/1658-354X.197369","article-title":"Effect of nebulized budesonide on respiratory mechanics and oxygenation in acute lung injury\/acute respiratory distress syndrome: randomized controlled study","volume":"11","author":"Mohamed","year":"2017","journal-title":"Saudi J Anaesth"},{"key":"2026012203473819600_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1152\/physrev.00003.2002","article-title":"Lung epithelial fluid transport and the resolution of pulmonary edema","volume":"82","author":"Matthay","year":"2002","journal-title":"Physiol Rev"},{"key":"2026012203473819600_bib33","doi-asserted-by":"crossref","first-page":"L52","DOI":"10.1152\/ajplung.00256.2006","article-title":"Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs","volume":"293","author":"Frank","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026012203473819600_bib34","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1164\/rccm.200503-451OC","article-title":"Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers","volume":"172","author":"Maris","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203473819600_bib35","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00134-002-1282-x","article-title":"Aerosolized \u03b22-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure","volume":"28","author":"Atabai","year":"2002","journal-title":"Intensive Care Med"},{"key":"2026012203473819600_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(11)61623-1","article-title":"Effect of intravenous \u03b2-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial","volume":"379","author":"Gao Smith","year":"2012","journal-title":"Lancet"},{"key":"2026012203473819600_bib37","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1164\/rccm.201012-2090OC","article-title":"Randomized, placebo-controlled clinical trial of an aerosolized \u03b22-agonist for treatment of acute lung injury","volume":"184","author":"Matthay","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203473819600_bib38","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0002-9440(10)64455-0","article-title":"Fas and Fas ligand are up-regulated in pulmonary edema fluid and lung tissue of patients with acute lung injury and the acute respiratory distress syndrome","volume":"161","author":"Albertine","year":"2002","journal-title":"Am J Pathol"},{"key":"2026012203473819600_bib39","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1164\/rccm.201308-1549OC","article-title":"The beta agonist lung injury trial prevention: a randomized controlled trial","volume":"189","author":"Perkins","year":"2014","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/18\/4\/698\/66338949\/annalsats_18_4_698.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/18\/4\/698\/66338949\/annalsats_18_4_698.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:53:25Z","timestamp":1769072005000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/18\/4\/698\/8419569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,1]]},"published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202009-1115sd","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4]]},"published":{"date-parts":[[2021,4,1]]},"assertion":[{"value":"2020-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}